Available to sourceHuman Prescription DrugNeurological & Psychiatric

AUVELITY (dextromethorphan hydrobromide, bupropion hydrochloride)

105 mg/1 / 30 mg/1 · Tablet Multilayer Extended Release

By Axsome Therapeutics, Inc.

NDC: 81968-030
Route: Oral
Therapeutic class: Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA], Sigma-1 Agonist , Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist , Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Neurological & Psychiatric

See all →

AUVELITY (dextromethorphan hydrobromide, bupropion hydrochloride)

Additional information

Request this medication

Related in Neurological & Psychiatric

GUNA-MOOD

Neuro Links

Allergy Rescue

New Stock Fungi Mix